Skip to main content
Citta Delcapo News

Life

Health, medicine, wellness, beauty, nutrition, and organic living.

Read FDA to Reassess Ebvallo After Unexpected Rejection

FDA to Reassess Ebvallo After Unexpected Rejection

Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.

Editorial Staff May 7
Read Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion

Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion

In a significant move within the pharmaceutical industry, Angelini Pharma has announced its acquisition of Catalyst Pharmaceuticals, a company specializing in treatments for rare diseases, for $4.1 billion.

Editorial Staff May 7
Read Understanding Variability in Parkinson's Treatment Response

Understanding Variability in Parkinson's Treatment Response

A recent study utilizing machine learning has revealed previously unrecognized forms of Parkinson's disease, potentially shedding light on the varying effectiveness of treatments among patients.

Editorial Staff May 7